- $13.11bn
- $14.45bn
- $3.27bn
- 85
- 35
- 66
- 66
Annual income statement for IDEX, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 2,352 | 2,765 | 3,182 | 3,274 | 3,269 |
| Cost of Revenue | |||||
| Gross Profit | 1,027 | 1,225 | 1,427 | 1,447 | 1,445 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 1,831 | 2,128 | 2,396 | 2,457 | 2,588 |
| Operating Profit | 521 | 637 | 786 | 817 | 681 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 470 | 580 | 749 | 760 | 639 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 378 | 449 | 587 | 596 | 505 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 378 | 449 | 587 | 596 | 505 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 378 | 449 | 587 | 596 | 505 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 5.27 | 6.49 | 7.76 | 7.14 | 7.24 |
| Dividends per Share |